Pharmacist-Led PEP/PrEP: A Comprehensive HIV Prevention Guide and Skills Assessment Activity
This two-part activity will provide continuing pharmacy education (CPE) to pharmacists who contribute or will contribute to HIV prevention, addressing knowledge and practice gaps identified among pharmacists and provide the clinical tools necessary for pharmacists to fulfill active roles within interdisciplinary HIV-prevention teams.
Adapting HIV Treatment for People with Substance Use Disorder
In this activity, an expert discusses how to adapt HIV treatment for people with substance use disorders, exploring barriers to management, effective communication strategies, coordinating care with mental health and substance use treatment providers, and guideline recommendations for developing HIV care plans.
Aging with HIV: Understanding the Journey
Join Gilead Sciences and the American Society on Aging for a series of podcast conversations about caring for older adults living with HIV.
Aging and PrEP: Considerations for PrEP in People 50 Years of Age and Older
Ensuring older adults have access to PrEP is a key step towards ending the HIV epidemic in the U.S. This webinar will present considerations around medical, counseling, and educational strategies to improve the uptake of PrEP among people aged 50 and older. It will highlight the benefits and opportunities of using PrEP in this population in efforts to decrease the rate of new HIV infections among people over 50. Presenters will focus on practical strategies for engaging older adults, such as culturally competent messaging and sexual history taking.
Integrating Frailty and Functional Outcomes into Clinical Trials
CROI Presentation: Considerations of frailty and functional outcomes for better integration and representation of aging patients in clinical trials.
HIV Clinical, Comorbid, and Social Determinants of Health are Linked with Brain Aging
CROI Presentation: Findings indicate that comorbid and social determinants of health are associated with brain ageing in people with HIV, alongside traditional HIV metrics such as viral load and CD4 cell count, suggesting the need for a broadened clinical perspective on healthy ageing with HIV, with additional focus on comorbidities, lifestyle changes, and social factors.
The Science of Aging: Lessons for HIV at the Interface of Commonality and Heterogeneity
CROI Presentation: Dr Kuchel said: ’20 years Difference between HIV + vs HIV- in this chart’ – “These things are Happening A lot Earlier for PWH than they should be, by 20 years. I would expect 80 year olds to have this level of syndromes, but these PWH are still 60 yrs old or younger.”
HIV and Aging: Double Stigma
HIV and ageism continue to be key public health challenges in the USA and globally. Older people living with HIV may experience intersectional stigma resulting from HIV and ageism. The current review summarizes the scientific literature and focuses on social isolation and lack of social support as key factors in experiencing HIV-related and aging-related stigma.
National HIV Curriculum: HIV in Older Adults
The shift of the HIV epidemic to increasingly involve older persons highlights several health care needs: (1) medical care systems with the capacity to provide clinical services for a large cohort of older persons with HIV, (2) active screening programs to detect HIV in older persons, and (3) implementation of strategies to prevent forward transmission of HIV from older persons.
Optimizing HIV Care for People Aging with HIV
The purpose of this reference guide is to identify commonly occurring health care and social needs of people aging with HIV and to highlight the screenings and assessments for these needs. This reference guide serves as a starting point for the health care team as it builds and expands its knowledge and practice of serving people aging with HIV.
